» Articles » PMID: 21188402

Genetic Aspects of Premature Ovarian Failure: a Literature Review

Overview
Date 2010 Dec 29
PMID 21188402
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The diagnosis of premature ovarian failure (POF) is based on the finding of amenorrhea before the age of 40 years associated with follicle-stimulating hormone levels in the menopausal range. It is a heterogeneous disorder affecting approximately 1% of women <40 years, 1:10,000 women by age 20 years and 1:1,000 women by age 30 years. POF is generally characterized by low levels of gonadal hormones (estrogens and inhibins) and high levels of gonadotropins (LH and FSH) (hypergonadotropic amenorrhea).

Methods: Review of significant articles regarding genetic causes that are associated with POF.

Results: Heterogeneity of POF is reflected by a variety of possible causes, including autoimmunity, toxics, drugs, as well as genetic defects. Changes at a single autosomal locus and many X-linked loci have been implicated in women with POF. X chromosome abnormalities (e.g., Turner syndrome) represent the major cause of primary amenorrhea associated with ovarian dysgenesis. Many genes have been involved in POF development, among them BMP15, FMR1, FMR2, LHR, FSHR, INHA, FOXL2, FOXO3, ERα, SF1, ERβ and CYP19A1 genes.

Conclusion: Despite the description of several candidate genes, the cause of POF remains undetermined in the vast majority of cases.

Citing Articles

Transcriptional Integration of Meiotic Prophase I Progression and Early Oocyte Differentiation.

Abt K, Bartholomew M, Nixon A, Richman H, Gura M, Seymour K bioRxiv. 2025; .

PMID: 39829852 PMC: 11741336. DOI: 10.1101/2025.01.06.631470.


Identifying therapeutic targets for primary ovarian insufficiency through integrated genomic analyses.

Du H, Zeng P, Liu X, Zhang J, Huang Z J Ovarian Res. 2024; 17(1):193.

PMID: 39358799 PMC: 11446024. DOI: 10.1186/s13048-024-01524-y.


X chromosome rearrangement associated with premature ovarian insufficiency as diagnosed by molecular cytogenetic methods: a case report and review of the literature.

Peng Z, Yang R, Liu Q, Chen B, Long P Mol Cytogenet. 2024; 17(1):7.

PMID: 38570848 PMC: 10988863. DOI: 10.1186/s13039-024-00676-2.


Targeting Estrogen Receptor Beta Ameliorates Diminished Ovarian Reserve via Suppression of the FOXO3a/Autophagy Pathway.

Li F, Zhu J, Liu J, Hu Y, Wu P, Zeng C Aging Dis. 2024; .

PMID: 38421826 PMC: 11745447. DOI: 10.14336/AD.2024.0221.


HNF1A gene mutations and premature ovarian failure (POF): evidence from a clinical paradigm combining MODY 3 and POF.

Xekouki P, Konstantinidou A, Tatsi C, Sertedaki A, Settas N, Loutradis D Hormones (Athens). 2024; 23(2):345-350.

PMID: 38311659 PMC: 11219395. DOI: 10.1007/s42000-024-00529-y.